Barbara Ann Karmanos Cancer Institute is a clinical research site located in Michigan Center, Michigan, United States 48201.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Barbara Ann Karmanos Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Advanced Refractory Solid Tumors, Subjects Considered Likely to Respond to CB-03-10.
Sponsors: Cosmo Technologies Ltd.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Barbara Ann Karmanos Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Barbara Ann Karmanos Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Refractory Solid Tumors, Subjects Considered Likely to Respond to CB-03-10.
Barbara Ann Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.